At ACC 2026, retrospective results were presented demonstrating the possibility of using pharmacotherapies for patients after ...

John Cantrell was enjoying his retirement until an unexpected condition forced him to choose between two kinds of heart ...

Transcatheter aortic valve replacement with self-expanding valves was associated with significantly lower mean aortic valve ...

Background Transcatheter aortic valve replacement (TAVR) has already been recommended for some high-risk patients with aortic valve regurgitation, but there is still a lack of evidence regarding its ...

Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...

Cardiovascular disease may be one of medicine’s oldest battlegrounds, but some of its most important technologies are still ...

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...

Emboline's Emboliner system excels in a global trial, showing superior debris capture and procedural success in TAVR patients ...

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...

Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...

Transcatheter aortic valve replacement (TAVR) yielded clinical benefit when given early in the disease process while patients still had no symptoms or other indication for aortic valve replacement, ...